Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in amazon basin communities

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Santelli, Ana C ^a   Ribeiro, Isabela ^c   Daher, André ^b,c   Boulos, Marcos ^d   Marchesini, Paola B ^e   Dos Santos, Roseli La Corte ^f   Lucena, Marize Bf ^g   Magalhães, Izanelda ^g   Leon, Antonio P ^h   Junger, Washington ^h   Ladislau, José Lb ^a  

^a MINISTÉRIO DA SAÚDE   (Brazil)

^b Drugs for Neglected Diseases Initiative   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e PAN AMERICAN HEALTH ORGANIZATION   (Brazil)

^f FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^g AC   (Brazil)

^h STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

ACT; Amazon; artesunate; Brazil; Fixed dose combination; Malaria; mefloquine; P. falciparum

Indexed keywords

ARTESUNATE PLUS MEFLOQUINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; CHILD; DISEASE COURSE; DIZZINESS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; SCHOOL CHILD; SEASONAL VARIATION; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; ARTEMISININS; BRAZIL; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MEFLOQUINE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865048317     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-286     Document Type: Article

References (30)

1. WHO, Guidelines for the treatment of malaria Geneva, Switzerland: World Health Organization 2010
2. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13years of continuous deployment. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F, PLoS ONE 2009 4 4551 10.1371/journal.pone.0004551 19234601
3. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Eh JP, Chongsuphajaisiddhi T, White NJ, J Infect Dis 1994 170 971 977 10.1093/infdis/170.4.971 7930743
4. Artemisinin-based combination treatment of falciparum malaria. Nosten F, White NJ, Am J Trop Med Hyg 2007 77 181 192 18165491
5. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Denis MB, Tsuyuoka R, Poravuth Y, Narann TS, Seila S, Lim C, Incardona S, Lim P, Sem R, Socheat D, Christophel EM, Ringwald P, Trop Med Int Health 2006 11 1360 1366 10.1111/j.1365-3156.2006.01690.x 16930257
6. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S, White NJ, Lancet 2000 356 297 302 10.1016/S0140-6736(00)02505-8 11071185
7. Efficacy of chloroquine+sulfadoxine-pyrimethamine, mefloquine+artesunate and artemether+lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. van den Broek IV, Maung UA, Peters A, Liem L, Kamal M, Rahman M, Rahman MR, Bangali AM, Das S, Barends M, Faiz AM, Trans R Soc Trop Med Hyg 2005 99 727 735 10.1016/j.trstmh.2005.02.007 16095643
8. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Price RN, Nosten F, Luxemburger C, van Vugt M, Phaipun L, Chongsuphajaisiddhi T, White NJ, Trans R Soc Trop Med Hyg 1997 91 574 577 10.1016/S0035-9203(97)90032-8 9463672
9. An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. Ashley EA, Lwin KM, McGready R, Simon WH, Phaiphun L, Proux S, Wangseang N, Taylor W, Stepniewska K, Nawamaneerat W, Thwai KL, Barends M, Leowattana W, Olliaro P, Singhasivanon P, White NJ, Nosten F, Trop Med Int Health 2006 11 1653 1660 10.1111/j.1365-3156. 2006.01724.x 17054744
10. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine. Krudsood S, Looareesuwan S, Tangpukdee N, Wilairatana P, Phumratanaprapin W, Leowattana W, Chalermrut K, Ramanathan S, Navaratnam V, Olliaro P, Vaillant M, Kiechel JR, Taylor WR, Antimicrob Agents Chemother 2010 54 3730 3737 10.1128/AAC.01187-09 20547795
11. WHO, World Health Organization Geneva, Switzerland: World malaria report 2009
12. Malaria in Brazil: an overview. Oliveira-Ferreira J, Lacerda MV, Brasil P, Ladislau JL, Tauil PL, Daniel-Ribeiro CT, Malar J 2010 9 115 10.1186/1475-2875-9-115 20433744
13. Manual de Terapêutica da Malária, Manual de Terapêutica da Malária Ministério da Saúde: Manual de Terapêutica da Malária 2003
14. In vitro drug sensitivity of Plasmodium falciparum in Acre, Brazil. Kremsner PG, Zotter GM, Feldmeier H, Graninger W, Kollaritsch M, Wiedermann G, Rocha RM, Wernsdorfer WH, Bull World Health Organ 1989 67 289 293 2670298
15. Drug susceptibility of Plasmodium falciparum in the western Amazon region, State of Acre, Brazil. Neifer S, Kremsner PG, Rev Inst Med Trop Sao Paulo 1991 33 205 211 1844536
16. Evidence-based public health and prospects for malaria control in Brazil. Ferreira MU, Da Silva-Nunes M, J Infect Dev Ctries 2010 4 533 545 21045365
17. Marquino W, Zegarra J, Neyra D, Villaroel R, Avila JC, Diaz C, Beltran E: Practical aspects of in vivo antimalarial drug efficacy testing in the Americas. Ruebush TK 2nd, Am J Trop Med Hyg 2003 68 391 397 12875285
18. Non-planed urbanization as a contributing factor for malaria incidence in Manaus-Amazonas, Brazil. Ferreira Goncalves MJ, Alecrim WD, Rev Salud Publica (Bogota) 2004 6 156
19. Implementation of Artemisinin Combination Therapies (ACTs): Role of ASMQ
20. High prevalence of asymptomatic malaria in gold mining areas in Brazil. de Andrade AL, Martelli CM, Oliveira RM, Arias JR, Zicker F, Pang L, Clin Infect Dis 1995 20 475 10.1093/clinids/20.2.475 7742465
21. Epidemiology of malaria in a hypoendemic Brazilian Amazon migrant population: a cohort study. Duarte EC, Gyorkos TW, Pang L, Abrahamowicz M, Am J Trop Med Hyg 2004 70 229 237 15031509
22. Ecologic observations on anopheline vectors of malaria in the Brazilian Amazon. Tadei WP, Thatcher BD, Santos JM, Scarpassa VM, Rodrigues IB, Rafael MS, Am J Trop Med Hyg 1998 59 325 335 9715956
23. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster, Trans R Soc Trop Med Hyg 2000 94 1 1 90 10.1016/S0035-9203(00) 90413-9 10748883
24. A theory for record linkage. Fellegi IP, Sunter AB, Journal of the American Statistical Association 1969 64 1183 1210 10.1080/01621459.1969. 10501049
25. Coeili CM: Reclink: aplicativo para o relacionamento de bases de dados, implementando o método probabilistic record linkage. Camargo KR Jr, Cad Saúde Pública 2000 16 439 447 23016718
26. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, South Africa. PLoS Med 2005 2 330
27. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ, Lancet Infect Dis 2010 10 673 681 10.1016/S1473-3099(10)70187-0 20832366
28. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative. Carrara VI, Sirilak S, Thonglairuam J, Rojanawatsirivet C, Proux S, Gilbos V, Brockman A, Ashley EA, McGready R, Krudsood S, Leemingsawat S, Looareesuwan S, Singhasivanon P, White N, Nosten F, PLoS Med 2006 3 183 10.1371/journal.pmed.0030183 16719547
29. Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria. Ashley EA, Stepniewska K, Lindegardh N, McGready R, Hutagalung R, Hae R, Singhasivanon P, White NJ, Nosten F, Antimicrob Agents Chemother 2006 50 2281 2285 10.1128/AAC.00040-06 16801402
30. Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance. Simpson JA, Watkins ER, Price RN, Aarons L, Kyle DE, White NJ, Antimicrob Agents Chemother 2000 44 3414 3424 10.1128/AAC.44.12.3414- 3424.2000 11083649